Study on the therapeutic mechanism of Tumor Treating Fields (TTFields) and Trihexyphenidyl （THP） and identification of clinical predictive expression signature for glioblastoma
- Weitere Titel
-
Studie zum therapeutischen Mechanismus von Tumor Treating Fields (TTFields) und Trihexyphenidyl (THP) und Identifizierung der klinisch prädiktiven Expressionssignatur für Glioblastome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2023
- Schlagwort
-
Krebs
Therapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Düsseldorf
- (wer)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (wann)
-
2023
- Urheber
- Beteiligte Personen und Organisationen
-
Kahlert, Ulf Dietrich
Berndt, Carsten
- URN
-
urn:nbn:de:hbz:061-20231120-103906-3
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Du, Renfei
- Kahlert, Ulf Dietrich
- Berndt, Carsten
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Entstanden
- 2023
Ähnliche Objekte (12)
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
A connectivity signature for glioblastoma [Abstract]
Therapeutic Potential of Selenium in Glioblastoma
443-446, The Therapeutic Community - Whom are we treating?
Targeted therapy to overcome the blood-brain barrier in treating Glioblastoma
SUMOylation in glioblastoma : a novel therapeutic target
EGFR and mTOR as therapeutic targets in glioblastoma
Therapeutic potential of thyroid hormone analogs in treating Allan-Herndon-Dudley syndrome
Therapeutic inhibition of the activated leukocyte integrin αMβ2 : a novel therapeutic strategy in treating myocarditis in mice
Cannabidiol for glioblastoma therapy : models, molecular pathways, and predictive markers
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
Using screening approaches to identify novel therapeutic agents for glioblastoma
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
A connectivity signature for glioblastoma [Abstract]
Therapeutic Potential of Selenium in Glioblastoma
443-446, The Therapeutic Community - Whom are we treating?
Targeted therapy to overcome the blood-brain barrier in treating Glioblastoma
SUMOylation in glioblastoma : a novel therapeutic target
EGFR and mTOR as therapeutic targets in glioblastoma
Therapeutic potential of thyroid hormone analogs in treating Allan-Herndon-Dudley syndrome
Therapeutic inhibition of the activated leukocyte integrin αMβ2 : a novel therapeutic strategy in treating myocarditis in mice
Cannabidiol for glioblastoma therapy : models, molecular pathways, and predictive markers
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
Using screening approaches to identify novel therapeutic agents for glioblastoma
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
A connectivity signature for glioblastoma [Abstract]
Therapeutic Potential of Selenium in Glioblastoma
443-446, The Therapeutic Community - Whom are we treating?
Targeted therapy to overcome the blood-brain barrier in treating Glioblastoma
SUMOylation in glioblastoma : a novel therapeutic target
EGFR and mTOR as therapeutic targets in glioblastoma
Therapeutic potential of thyroid hormone analogs in treating Allan-Herndon-Dudley syndrome
Therapeutic inhibition of the activated leukocyte integrin αMβ2 : a novel therapeutic strategy in treating myocarditis in mice
Cannabidiol for glioblastoma therapy : models, molecular pathways, and predictive markers
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability